Literature DB >> 15448092

Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation.

Patricia Vuguin1, Elisabeth Raab, Bing Liu, Nir Barzilai, Rebecca Simmons.   

Abstract

Intrauterine growth retardation (IUGR) has been linked to the development of type 2 diabetes in adulthood. We developed an IUGR model in rats whereby at age 3-6 months the animals develop a diabetes that is associated with insulin resistance. Hyperinsulinemic-euglycemic clamp studies were performed at age 8 weeks, before the onset of obesity and diabetes. Basal hepatic glucose production (HGP) was significantly higher in IUGR than in control rats (14.6 +/- 0.4 vs. 12.3 +/- 0.3 mg. kg(-1). min(-1); P < 0.05). Insulin suppression of HGP was blunted in IUGR versus control rats (10.4 +/- 0.6 vs. 6.5 +/- 1.0 mg. kg(-1). min(-1); P < 0.01); however, rates of glucose uptake and glycogenolysis were similar between the two groups. Insulin-stimulated insulin receptor substrate 2 and Akt-2 phosphorylation were significantly blunted in IUGR rats. PEPCK and glucose-6-phosphatase mRNA levels were increased at least threefold in liver of IUGR compared with control rats. These studies suggest that an aberrant intrauterine milieu permanently impairs insulin signaling in the liver so that gluconeogenesis is augmented in the IUGR rat. These processes occur early in life, before the onset of hyperglycemia, and indicate that uteroplacental insufficiency causes a primary defect in gene expression and hepatic metabolism that leads to the eventual development of overt hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15448092     DOI: 10.2337/diabetes.53.10.2617

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  47 in total

Review 1.  Adult sequelae of intrauterine growth restriction.

Authors:  Michael G Ross; Marie H Beall
Journal:  Semin Perinatol       Date:  2008-06       Impact factor: 3.300

2.  Coordinated changes in hepatic amino acid metabolism and endocrine signals support hepatic glucose production during fetal hypoglycemia.

Authors:  Satya S Houin; Paul J Rozance; Laura D Brown; William W Hay; Randall B Wilkening; Stephanie R Thorn
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

3.  Differential effects of intrauterine growth restriction and a hypersinsulinemic-isoglycemic clamp on metabolic pathways and insulin action in the fetal liver.

Authors:  Amanda K Jones; Laura D Brown; Paul J Rozance; Natalie J Serkova; William W Hay; Jacob E Friedman; Stephanie R Wesolowski
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-02-13       Impact factor: 3.619

Review 4.  Fetal programming and cardiovascular pathology.

Authors:  Barbara T Alexander; John Henry Dasinger; Suttira Intapad
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

5.  Developmental origins of diabetes: The role of oxidative stress.

Authors:  Rebecca A Simmons
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-04       Impact factor: 4.690

6.  Superimposition of postnatal calorie restriction protects the aging male intrauterine growth- restricted offspring from metabolic maladaptations.

Authors:  Yun Dai; Shanthie Thamotharan; Meena Garg; Bo-Chul Shin; Sherin U Devaskar
Journal:  Endocrinology       Date:  2012-07-17       Impact factor: 4.736

7.  Detection of expressional changes induced by intrauterine growth restriction in the developing rat pancreas.

Authors:  Lin Zhang; Wei Chen; Yuee Dai; Ziyang Zhu; Qianqi Liu
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-17

8.  Cytosine methylation dysregulation in neonates following intrauterine growth restriction.

Authors:  Francine Einstein; Reid F Thompson; Tushar D Bhagat; Melissa J Fazzari; Amit Verma; Nir Barzilai; John M Greally
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

Review 9.  Perinatal programming of obesity.

Authors:  Rebecca Simmons
Journal:  Semin Perinatol       Date:  2008-10       Impact factor: 3.300

Review 10.  Targeting xenobiotic receptors PXR and CAR for metabolic diseases.

Authors:  Jie Gao; Wen Xie
Journal:  Trends Pharmacol Sci       Date:  2012-08-10       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.